| Literature DB >> 30157427 |
Yanfang Peipei Zhu1, Lindsey Padgett2, Huy Q Dinh2, Paola Marcovecchio2, Amy Blatchley2, Runpei Wu2, Erik Ehinger2, Cheryl Kim3, Zbigniew Mikulski2, Gregory Seumois4, Ariel Madrigal4, Pandurangan Vijayanand4, Catherine C Hedrick5.
Abstract
Neutrophils are short-lived cells that play important roles in both health and disease. Neutrophils and monocytes originate from the granulocyte monocyte progenitor (GMP) in bone marrow; however, unipotent neutrophil progenitors are not well defined. Here, we use cytometry by time of flight (CyTOF) and single-cell RNA sequencing (scRNA-seq) methodologies to identify a committed unipotent early-stage neutrophil progenitor (NeP) in adult mouse bone marrow. Importantly, we found a similar unipotent NeP (hNeP) in human bone marrow. Both NeP and hNeP generate only neutrophils. NeP and hNeP both significantly increase tumor growth when transferred into murine cancer models, including a humanized mouse model. hNeP are present in the blood of treatment-naive melanoma patients but not of healthy subjects. hNeP can be readily identified by flow cytometry and could be used as a biomarker for early cancer discovery. Understanding the biology of hNeP should allow the development of new therapeutic targets for neutrophil-related diseases, including cancer.Entities:
Keywords: CyTOF; T cell suppression; granulopoiesis; melanoma; neutrophil progenitor; sarcoma; scRNA-seq
Mesh:
Year: 2018 PMID: 30157427 PMCID: PMC6542273 DOI: 10.1016/j.celrep.2018.07.097
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423